NorthX Biologics is Beyond CDMO

Janet Hoogstraate, CEO and Eva-karin Gidlund, Chief Business Officer, and Magnus Gustafsson, Chief Commercial Officer, all with NorthX Biologics, discuss their CDMO customizable services for both large and smaller developers. They view themselves as a partner on their clients' journey to getting their therapies to patients. NorthX Biologics specializes in modalities including plasmids, mRNA, proteins, viruses, and viral vectors. To stay up to date and equipped to help their clients, they seek our collaborations to find services and solutions, or through acquisition, bringing up to date technology in-house. The company has very strong relationships in Europe and in the United States.